Eblasakimab:Study of Eblasakimab in Male or Female Moderate

Study of Eblasakimab in Male or Female Moderate

Study of Eblasakimab in Male or Female Moderate

2023年1月23日—StudyofEblasakimabinMaleorFemaleModerate-to-SevereAtopicDermatitisPatientsPreviouslyTreatedWithDupilumab;ASLANInvestigativeSite ...。其他文章還包含有:「Eblasakimab」、「EblasakimabMonthlyDosingShowsPotentialforBest」、「Eblasakimab,anovelIL」、「Eblasakimab」

查看更多 離開網站